Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) EPS (Weighted Average and Diluted) (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with -$0.12 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 20.0% to -$0.12 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.33 through Dec 2025, up 2.94% year-over-year, with the annual reading at $0.5 for FY2025, 338.1% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.12 at Strata Critical Medical, roughly flat from -$0.12 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.1 in Q2 2022, with the low at -$0.47 in Q2 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.13, with a median of -$0.12 recorded in 2021.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 3172.3% in 2021, then soared 121.28% in 2022.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $0.01 in 2021, then tumbled by 2200.0% to -$0.21 in 2022, then tumbled by 119.05% to -$0.46 in 2023, then skyrocketed by 78.26% to -$0.1 in 2024, then decreased by 20.0% to -$0.12 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.12, -$0.12, and -$0.05 for Q4 2025, Q3 2025, and Q2 2025 respectively.